Mannheimia haemolytica (Newsom and Cross) Angen et al.
商品貨號(hào)
B169037
Deposited As
Pasteurella haemolytica Newsom and Cross
Application
Produces leukotoxin
Isolation
Bovine pneumonia, California
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Antigenic Properties
Serotype 1
Product Format
freeze-dried
Disclosure
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC.
Preceptrol®
no
Type Strain
no
Comments
Challenge exposure after immunization
Medium
ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood
Shewen PE, Wilkie BN. Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes. Infect. Immun. 35: 91-94, 1982. PubMed: 7054131
Wilkie BN, et al. Response of calves to lung challenge exposure with Pasteurella haemolytica after parenteral or pulmonary immunization. Am. J. Vet. Res. 41: 1773-1778, 1980. PubMed: 7212406
Shewen PE, Wilkie BN. Evidence for the Pasteurella haemolytica cytotoxin as a product of actively growing bacteria. Am. J. Vet. Res. 46: 1212-1214, 1985. PubMed: 4003897
